The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

Dec. 07, 2007
Applicants:

Justin M. Lira, Fishers, IN (US);

Terry R. Wright, Carmel, IN (US);

Sean M. Russell, Carmel, IN (US);

Donald J. Merlo, Carmel, IN (US);

Steven R. Webb, Westfield, IN (US);

Nicole L. Arnold, Carmel, IN (US);

Andrew E. Robinson, Brownsburg, IN (US);

Kelley A. Smith, Lebanon, IN (US);

Inventors:

Justin M. Lira, Fishers, IN (US);

Terry R. Wright, Carmel, IN (US);

Sean M. Russell, Carmel, IN (US);

Donald J. Merlo, Carmel, IN (US);

Steven R. Webb, Westfield, IN (US);

Nicole L. Arnold, Carmel, IN (US);

Andrew E. Robinson, Brownsburg, IN (US);

Kelley A. Smith, Lebanon, IN (US);

Assignee:

Dow AgroSciences LLC, Indianapolis, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/82 (2006.01);
U.S. Cl.
CPC ...
C12N 15/8277 (2013.01); C12N 15/8209 (2013.01);
Abstract

The subject invention relates to a novel gene referred to herein as DSM-2. This gene was identified inA3. The DSM-2 protein is distantly related to PAT and BAR. The subject invention also provides plant-optimized genes encoding DSM-2 proteins, DSM-2 can be used as a transgenic trait to impart tolerance in plants and plant cells to the herbicides glufosinate and bialaphos. One preferred use of the subject genes are as selectable markers. The use of this gene as a selectable marker in a bacterial system can increase efficiency for plant transformations. Use of DSM-2 as the sole selection marker eliminates the need for an additional medicinal antibiotic marker (such as ampicillin resistance) during cloning. Various other uses are also possible according to the subject invention.


Find Patent Forward Citations

Loading…